Central administration of [Phe1Ψ(CH2-NH)Gly2]Nociceptin(1-13)-NH2 and orphanin FQ/Nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 1, 1999, Pages 173-180

  Kapusta, Daniel R ^a   Chang, Jaw Kang ^b   Kenigs, Velga A ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b PHOENIX PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

[1 PHENYLALANYL PSI(METHYLAMINO) 2 GLYCINE]NOCICEPTIN[1-13] AMIDE; KAPPA OPIATE RECEPTOR; NOCICEPTIN RECEPTOR; OPIATE ANTAGONIST; OPIATE RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; NOCICEPTIN; NOCICEPTIN (1 13) NH2, PHE(1) PSI(CH2 NH) GLY(2); NOCICEPTIN (1-13)-NH2, PHE(1)-PSI(CH2-NH)-GLY(2)-; OPIATE PEPTIDE; PEPTIDE FRAGMENT;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HEART RATE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; KIDNEY FUNCTION; LIGAND BINDING; MALE; MEAN ARTERIAL PRESSURE; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM URINE LEVEL; ANIMAL; BLOOD PRESSURE; COMPARATIVE STUDY; HEMODYNAMICS; KIDNEY; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; URODYNAMICS;

ANIMALS; BLOOD PRESSURE; HEART RATE; HEMODYNAMIC PROCESSES; INJECTIONS, INTRAVENTRICULAR; KIDNEY; MALE; OPIOID PEPTIDES; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; URODYNAMICS;

EID: 0032588528     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bunzow JR, Saez C, Mortrud M, Bouvier C, Williams JT, Low M and Grandy DK (1994) Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ, or κ opioid receptor type. FEBS Lett 347:284-288.
2. Calo G, Rizzi A, Bodin M, Neugebauer W, Salvadori S, Guerrini R, Bianchi C and Regoli D (1997) Pharmacological characterization of nociceptin receptor: An in vitro study. Can J Physiol Pharmacol 75:713-718.
3. Calo G, Rizzi A, Bogoni G, Neugebauer V, Salvadori S, Guerrini R, Bianchi C and Regoli D (1996) The mouse vas deferens: A pharmacological preparation sensitive to nociceptin. Eur J Pharmacol 311:R3-R5.
4. Caudle RM, Mannes AJ and Iadarola J (1997) GR89,696 is a kappa-2 opioid receptor agonist and a kappa-1 opioid receptor antagonist in the guinea pig hippocampus. J Pharmacol Exp Ther 283:1342-1349.
5. Champion HC and Kadowitz PJ (1997) [Tyr1-nociceptin has naloxone-insensitive vasodilator activity in the hindquarters vascular bed of the rat. Life Sci 61:PL403-PL408.
6. Chen Y, Fan Y, Liu J, Mestek A, Tian M, Kozak CA and Yu L (1994) Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett 347:279-283.
7. Dunnill RJ, Kakizawa K, McKnight AT and Henderson G (1996) Characterization of the actions of naloxone benzoylhydrazone at μ-opioid, κ-opioid and ORL1 receptors in isolated tissues from rat and guinea-pig. Br J Pharmacol 119:275P.
8. Fowler CJ and Fraser GL (1994) μ-, δ-, κ-Opioid receptors and their subtypes: A critical review with emphasis on radioligand binding experiments. Neurochem Int 24:401-426.
9. Fukuda K, Kato S, Mon K, Nishi M, Takeshima H, Iwabe N, Miyata T, Houtani T and Siguimoti T (1994) cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett 343:42-46.
10. 1-opioid receptor antagonist. Eur J Pharmacol 316:33-38.
11. Guerrini R, Calo G, Rizzi A, Bianchi C, Lazarus LH, Salvadori S, Temussi PA and Regoli D (1997) Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin(1-13) amide. J Med Chem 40:1789-1793.
12. Guerrini R, Calo G, Rizzi A, Bigoni R, Bianchi C, Salvadori S and Regoli D (1998) A new selective antagonist of the nociceptin receptor. Br J Pharmacol 123:163-165.
13. Kapusta DR (1995) Opioid mechanisms controlling renal function. Clin Exp Pharmacol Physiol 22:891-902.
14. Kapusta DR, Jones SY and DiBona GF (1989) Opioids in the systemic hemodynamic and renal responses to stress in conscious spontaneously hypertensive rats. Hypertension 13:808-816.
15. Kapusta DR and Obih JC (1993) Central kappa opioid receptor-evoked changes in renal function in conscious rats: Participation of renal nerves. J Pharmacol Exp Ther 267:197-204.
16. Kapusta DR, Sezen SF, Chang J-K, Lippton H and Kenigs VA (1997) Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci 60:PL15-PL21.
17. Kenakin T and Beek D (1980) Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships. J Pharmacol Exp Ther 213:406-413.
18. Kenakin T and Beek D (1984) Relative efficacy of prenalterol and pirbuterol for beta-1 adrenoceptors: Measurement of agonist affinity by alteration of receptor number. J Pharmacol Exp Ther 229:340-345.
19. Koepke JP and DiBona GF (1986) Central adrenergic receptor control of renal function in conscious hypertensive rats. Hypertension 8:133-141.
20. Lachowicz JE Shen Y, Monsma FJ Jr and Sibley DR (1995) Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J Neurochem 64:34-40.
21. Mathis JP, Goldberg IE, Rossi GC, Leventhal L and Pasternak GW (1998) Antinociceptive analogs of orphanin FQ/nociceptin(1-11). Life Sci 63:PL161-PL166.
22. 14]orphanin FQ/nociceptin binding in mouse brain: Evidence for heterogeneity. Biochem Biophys Res Commun 230:462-465.
23. Matthes H, Seward EP, Kieffer B and North RA (1996) Functional selectivity of orphanin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes. Mol Pharmacol 50:447-450.
24. 1 receptor. Nature (London) 377:532-535.
25. Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G and Meunier JC (1994) ORL-1, a novel member of the opioid receptor family: Cloning, functional expression and localization. FEBS Lett 341:33-38.
26. Mogil JS, Grisel JE, Reinscheid RK, Civelli O, Belknap JK and Grandy DK (1996) Orphanin FQ is a functional anti-opioid peptide. Neuroscience 75:333-337.
27. 3-related opioid receptor using antisense oligodeoxynucleotides. Regul Pept 54:217-218.
28. 3-related opioid receptor. Mol Pharmacol 47:1180-1188.
29. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press. Australia.
30. Reinscheid RK, Ardati A, Monsma FJ Jr and Civelli O (1996) Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J Biol Chem 271: 14163-14168.
31. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ and Civelli O (1995) Orphanin FQ: A neuropeptide that activates an opioid-like G protein-coupled receptor. Science (Wash DC) 270:792-794.
32. Rossi GC, Leventhal L, Bolan E and Pasternak GW (1997) Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J Pharmacol Exp Ther 282:858-865.
33. Wang JB, Johnson PS, Imai Y, Persico AM, Ozenberger BA, Eppler CM and Uhl GR (1994) cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett 348:75-79.
34. Wick MJ, Minnerath SE, Lin X, Elde R, Law P-Y and Loh HH (1994) Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned μ, δ, and κ opioid receptors. Mol Brain Res 27:37-44.